Avantor Inc at Barclays Global Healthcare Conference Transcript
I guess we're good to go. Thank you, everybody. It's great to be in person again. Welcome to Barclays Conference. It's my pleasure to speak with Avantor and CFO, Thomas Szlosek.
With that, I guess we can dig right into it.
Questions & Answers
So Tom, plenty of macro, we got to kind of go over that first. So let's go in. I know you have small Ukraine, Russia exposure, but you guys have a pretty sizable European business. So are you starting to see any cracks there? Just give us an idea of how the demand environment played out versus your expectations throughout the quarter.
Yes. Yes. Thanks. Thanks, Luke, and good morning, everybody. Just to set things at the outset. From a guidance perspective, for 2022, Avantor had set out with 4% to 6% organic growth, roughly 125 basis points of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |